| 1 |
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation. ( 28913878
)
|
Campa D....Canzian F.
|
2018 |
| 2 |
Polycystic pancreatic disease associated with pineal cyst in an adolescent: a case report and literature overview. ( 29026573
)
|
Badran A.M....Kayemba Kay's S.
|
2017 |
| 3 |
The Burden of Systemic Adiposity on Pancreatic Disease: Acute Pancreatitis, Non-Alcoholic Fatty Pancreas Disease, and Pancreatic Cancer. ( 29491829
)
|
Malli A....Krishna S.G.
|
2017 |
| 4 |
Phenotype variability of infantile-onset multisystem neurologic, endocrine, and pancreatic disease IMNEPD. ( 27129381
)
|
Picker-Minh S....Kaindl A.M.
|
2016 |
| 5 |
The vitamin D system is deregulated in pancreatic diseases. ( 25090635
)
|
Hummel D....HorvA!th H.C.
|
2014 |
| 6 |
The clinical significance of somatostatin in pancreatic diseases. ( 25156131
)
|
SliwiA8ska-MossoA8 M....Milnerowicz H.
|
2014 |
| 7 |
Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization study. ( 24550193
)
|
Soave D....Strug L.J.
|
2014 |
| 8 |
Fecal elastase-1 is useful in the detection of steatorrhea in patients with pancreatic diseases but not after pancreatic resection. ( 23395568
)
|
Benini L....Frulloni L.
|
2013 |
| 9 |
ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. ( 23403949
)
|
Rizzato C....Canzian F.
|
2013 |
| 10 |
MRI manifestations of pancreatic disease, especially pancreatitis, in the pediatric population. ( 24261395
)
|
Thai T.C....Rust K.R.
|
2013 |
| 11 |
Severe pancreatic dysfunction but compensated nutritional status in monogenic pancreatic disease caused by carboxyl-ester lipase mutations. ( 23770712
)
|
Tjora E....RA
|
2013 |
| 12 |
Efficacy of low-fat diet against dyspepsia associated with nonalcoholic mild pancreatic disease diagnosed using the Rosemont criteria. ( 22836859
)
|
Maruki J....Watanabe S.
|
2013 |
| 13 |
Obstructive jaundice and pancreatic disease. ( 23069596
)
|
Deshmukh S....Smith A.M.
|
2012 |
| 14 |
Serum procarboxypeptidase A and carboxypeptidase A levels in pancreatic disease. ( 21502183
)
|
Kemik O....Tuzun S.
|
2012 |
| 15 |
Improved diagnostic accuracy of pancreatic diseases with a combination of various novel serum biomarkers--case control study from Manipal Teaching Hospital, Pokhara, Nepal. ( 22901189
)
|
Farooqui M.S....Farooqui M.H.
|
2012 |
| 16 |
Roles of serine protease inhibitor Kazal type 1 (SPINK1) in pancreatic diseases. ( 22041280
)
|
Ohmuraya M....Yamamura K.
|
2011 |
| 17 |
Mucin expression pattern in pancreatic diseases: findings from EUS-guided fine-needle aspiration biopsies. ( 21647207
)
|
Carrara S....Testoni P.A.
|
2011 |
| 18 |
Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers. ( 22220206
)
|
Yue T....Haab B.B.
|
2011 |
| 19 |
Autoimmune pancreatitis--a new evolving pancreatic disease? ( 20862490
)
|
Okazaki K....Nishio A.
|
2010 |
| 20 |
Efficacy of camostat mesilate against dyspepsia associated with non-alcoholic mild pancreatic disease. ( 19876587
)
|
Sai J.K....Watanabe S.
|
2010 |
| 21 |
[Hepato-biliary and pancreatic disease and osteodystrophy]. ( 19721198
)
|
Imaeda K....Nojiri S.
|
2009 |
| 22 |
The role of epoxide hydrolase Y113H gene variant in pancreatic diseases. ( 19287329
)
|
Ockenga J....Witt H.
|
2009 |
| 23 |
Autoimmune pancreatitis: disease evolution, staging, response assessment, and CT features that predict response to corticosteroid therapy. ( 19017924
)
|
Sahani D.V....Fernandez-del Castillo C.
|
2009 |
| 24 |
Rosiglitazone aggravates nonalcoholic Fatty pancreatic disease in C57BL/6 mice fed high-fat and high-sucrose diet. ( 19214135
)
|
Fernandes-Santos C....Mandarim-de-Lacerda C.A.
|
2009 |
| 25 |
Heat shock proteins in pancreatic diseases. ( 18336662
)
|
Saluja A....Dudeja V.
|
2008 |
| 26 |
Enhanced ENA-78 and IL-8 expression in patients with malignant pancreatic diseases. ( 18765953
)
|
Frick V.O....Schilling M.K.
|
2008 |
| 27 |
Serum adenosine deaminase levels in pancreatic diseases. ( 17901713
)
|
IbiA9 M....OztA1rk Z.A.
|
2007 |
| 28 |
Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease. ( 16920697
)
|
KA1nzli B.M....Robson S.C.
|
2007 |
| 29 |
Coincidental CFTR mutation and SjAPgren syndrome revealing a pancreatic disease. ( 17575550
)
|
Frossard J.L....Hadengue A.
|
2007 |
| 30 |
CEA, CA 19-9, and CA 125 in the differential diagnosis of benign and malignant pancreatic diseases with or without jaundice. ( 17262731
)
|
Duraker N....Urhan N.
|
2007 |
| 31 |
DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. ( 16424060
)
|
Matsubayashi H....Goggins M.
|
2006 |
| 32 |
Do cytokine concentrations in pancreatic juice predict the presence of pancreatic diseases? ( 16713745
)
|
Noh K.W....Raimondo M.
|
2006 |
| 33 |
Cystic fibrosis transmembrane regulator mutations and pancreatic disease: closing the gap between genotype and phenotype. ( 16427928
)
|
Morinville V....Slivka A.
|
2006 |
| 34 |
Novel serum tumor marker, RCAS1, in pancreatic diseases. ( 16127752
)
|
Yamaguchi K....Tanaka M.
|
2005 |
| 35 |
Polymorphisms of UDP-glucuronosyltransferase 1A7 are not involved in pancreatic diseases. ( 16199544
)
|
Verlaan M....Witt H.
|
2005 |
| 36 |
Detection of point mutation in K-ras oncogene at codon 12 in pancreatic diseases. ( 15040037
)
|
Ren Y.X....Song Y.G.
|
2004 |
| 37 |
Immunohistochemical localization of type IV collagen alpha chains in the basement membrane of the pancreatic duct in human normal pancreas and pancreatic diseases. ( 15211113
)
|
Kadono G....Saisho H.
|
2004 |
| 38 |
Determination of plasma glycoprotein 2 levels in patients with pancreatic disease. ( 15163232
)
|
Hao Y....Lowe A.W.
|
2004 |
| 39 |
Subcutaneous nodules pointing towards pancreatic disease: pancreatic panniculitis. ( 15308866
)
|
van der Zee J.A....Gouma D.J.
|
2004 |
| 40 |
A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases. ( 12952861
)
|
Lee J.H....Lee M.G.
|
2003 |
| 41 |
Human anionic trypsinogen: properties of autocatalytic activation and degradation and implications in pancreatic diseases. ( 12709065
)
|
Kukor Z....Sahin-TA^th M.
|
2003 |
| 42 |
Mutations of the CFTR gene in pancreatic disease. ( 14576497
)
|
Pezzilli R....Gullo L.
|
2003 |
| 43 |
[Genetic risk factors in pancreatic diseases--significance for general practice]. ( 12078388
)
|
Keim V.
|
2002 |
| 44 |
Genetics and pancreatic disease. ( 17033331
)
|
Schneider A....Whitcomb D.C.
|
2002 |
| 45 |
Secretin-mediated gene delivery, a specific targeting mechanism with potential for treatment of biliary and pancreatic disease in cystic fibrosis. ( 11945072
)
|
McKay T....Coutelle C.
|
2002 |
| 46 |
MR imaging of pancreatic diseases. ( 11335090
)
|
Ito K....Matsunaga N.
|
2001 |
| 47 |
Evaluation of the role of CFTR in alcohol related pancreatic disease. ( 11476081
)
|
Ockenga J....Manns M.P.
|
2001 |
| 48 |
Pancreatitis-associated protein levels in pancreatic juice from patients with pancreatic diseases. ( 12120267
)
|
Motoo Y....Sawabu N.
|
2001 |
| 49 |
Bombesin receptors in distinct tissue compartments of human pancreatic diseases. ( 11140694
)
|
Fleischmann A....Reubi J.C.
|
2000 |
| 50 |
Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease. ( 10690540
)
|
Wang L....BA1chler M.W.
|
2000 |
